Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer
Clinical trial NCT01218880 · UNKNOWN
Trial details
- NCT number
- NCT01218880
- Sponsor
- Protgen Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-07-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.